Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
Clinical and Experimental Rheumatology
|
November 6, 2014
Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters
A Fischer, J J Swigris, M B Bolster, et al.
The Journal of Rheumatology
|
March 7, 1998
Early undifferentiated connective tissue disease. V. An inception cohort 5 years later: disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseases
H J Williams, G S Alarcón, R Neuner, et al.
The Journal of Rheumatology
|
May 6, 1999
Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD
H J Williams, G S Alarcon, R Joks, et al.
Arthritis and Rheumatism
|
March 1, 1996
Early undifferentiated connective tissue disease. IV.Musculoskeletal manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of patients with well-established connective tissue diseases: followup analyses in patients with unexplained polyarthritis and patients with rheumatoid arthritis at baseline
G S Alarcón, R F Willkens, J R Ward, et al.
Arthritis and Rheumatism
|
May 20, 1998
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States
R C Lawrence, C G Helmick, F C Arnett, et al.
Annals of Internal Medicine
|
February 1, 1994
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study
F M Wigley, R A Wise, J R Seibold, et al.
The Journal of Rheumatology
|
October 21, 1999
A disease severity scale for systemic sclerosis: development and testing
T A Medsger, A J Silman, V D Steen, et al.
Annals of Internal Medicine
|
April 15, 1993
Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis)
K J Bulpitt, P J Clements, P A Lachenbruch, et al.
Arthritis and Rheumatism
|
November 18, 2000
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial
P J Clements, E L Hurwitz, W K Wong, et al.
Annals of the Rheumatic Diseases
|
March 17, 2006
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study
D Khanna, D E Furst, R D Hays, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
Clinical and Experimental Rheumatology
|
November 6, 2014
Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters
A Fischer, J J Swigris, M B Bolster, et al.
The Journal of Rheumatology
|
March 7, 1998
Early undifferentiated connective tissue disease. V. An inception cohort 5 years later: disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseases
H J Williams, G S Alarcón, R Neuner, et al.
The Journal of Rheumatology
|
May 6, 1999
Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD
H J Williams, G S Alarcon, R Joks, et al.
Arthritis and Rheumatism
|
March 1, 1996
Early undifferentiated connective tissue disease. IV.Musculoskeletal manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of patients with well-established connective tissue diseases: followup analyses in patients with unexplained polyarthritis and patients with rheumatoid arthritis at baseline
G S Alarcón, R F Willkens, J R Ward, et al.
Arthritis and Rheumatism
|
May 20, 1998
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States
R C Lawrence, C G Helmick, F C Arnett, et al.
Annals of Internal Medicine
|
February 1, 1994
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study
F M Wigley, R A Wise, J R Seibold, et al.
The Journal of Rheumatology
|
October 21, 1999
A disease severity scale for systemic sclerosis: development and testing
T A Medsger, A J Silman, V D Steen, et al.
Annals of Internal Medicine
|
April 15, 1993
Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis)
K J Bulpitt, P J Clements, P A Lachenbruch, et al.
Arthritis and Rheumatism
|
November 18, 2000
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial
P J Clements, E L Hurwitz, W K Wong, et al.
Annals of the Rheumatic Diseases
|
March 17, 2006
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study
D Khanna, D E Furst, R D Hays, et al.
Page
of 8